Skip to Content

Drug interactions between acetaminophen / pseudoephedrine / triprolidine and pseudoephedrine / triprolidine

Results for the following 2 drugs:
acetaminophen/pseudoephedrine/triprolidine
pseudoephedrine/triprolidine

Interactions between your drugs

There were no interactions found in our database between acetaminophen / pseudoephedrine / triprolidine and pseudoephedrine / triprolidine. However, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

acetaminophen / pseudoephedrine / triprolidine

A total of 967 drugs (5864 brand and generic names) are known to interact with acetaminophen / pseudoephedrine / triprolidine.

pseudoephedrine / triprolidine

A total of 890 drugs (5351 brand and generic names) are known to interact with pseudoephedrine / triprolidine.

Drug and food interactions

Moderate

triprolidine food

Applies to: acetaminophen / pseudoephedrine / triprolidine, pseudoephedrine / triprolidine

Alcohol can increase the nervous system side effects of triprolidine such as dizziness, drowsiness, and difficulty concentrating. Some people may also experience impairment in thinking and judgment. You should avoid or limit the use of alcohol while being treated with triprolidine. Do not use more than the recommended dose of triprolidine, and avoid activities requiring mental alertness such as driving or operating hazardous machinery until you know how the medication affects you. Talk to your doctor or pharmacist if you have any questions or concerns.

Switch to professional interaction data

Therapeutic duplication warnings

Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition. This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit. It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy, and can have potentially adverse consequences.

Duplication

Decongestants

Therapeutic duplication

The recommended maximum number of medicines in the 'decongestants' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'decongestants' category:

  • pseudoephedrine (active ingredient in acetaminophen/pseudoephedrine/triprolidine)
  • pseudoephedrine (active ingredient in pseudoephedrine/triprolidine)

Note: The benefits of taking this combination of medicines may outweigh any risks associated with therapeutic duplication. This information does not take the place of talking to your doctor. Always check with your healthcare provider to determine if any adjustments to your medications are needed.

Duplication

Antihistamines

Therapeutic duplication

The recommended maximum number of medicines in the 'antihistamines' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'antihistamines' category:

  • triprolidine (active ingredient in acetaminophen/pseudoephedrine/triprolidine)
  • triprolidine (active ingredient in pseudoephedrine/triprolidine)

Note: The benefits of taking this combination of medicines may outweigh any risks associated with therapeutic duplication. This information does not take the place of talking to your doctor. Always check with your healthcare provider to determine if any adjustments to your medications are needed.

Drug Interaction Classification

The classifications below are a guideline only. The relevance of a particular drug interaction to a specific patient is difficult to determine using this tool alone given the large number of variables that may apply.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide